Drug intelligence / Profile preview

Arginine silicate

Development stage
Unknown
Lead developer
Nutrition21
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Peptides, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Arginine silicate is a laboratory-synthesized compound consisting of the amino acid arginine, silicon (as silicate), and inositol bonded together to form a unique molecule. It is primarily used as a dietary supplement ingredient to increase plasma levels of both arginine and silicon more effectively than standard forms such as arginine hydrochloride[1][4][6]. The mechanism of action involves increasing blood levels of L-arginine, which serves as a precursor for nitric oxide synthesis—a key mediator of vasodilation and improved blood flow[1]. Silicon may enhance the bioavailability and absorption of L-arginine. Clinical studies have shown that supplementation with this complex can elevate plasma concentrations of both components within hours after ingestion and sustain these increases with continued use[1][4]. Arginine silicate has been investigated for potential benefits on vascular health, cognitive function, bone healing, exercise performance ("pump"), and possibly other areas where increased nitric oxide production or improved nutrient delivery are beneficial[2][4][6]. It is generally considered safe when used as directed.

Brand names
Nitrosigine
Other names
inositol-stabilized arginine silicatearginine silicate inositol complexASI
02

Targets

NOS2 (Nitric Oxide Synthase 2)NOS1 (nNOS)NOS3 (eNOS)

Beyond the preview

Go deeper on Arginine silicate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine silicate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call